-
Cgp 33304
- names:
sodium 5-((5-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy)-4-bromo-2-methylphenyl)carbamoyl)tetrazol-1-ide
- CAS号:
111130-14-4
MDL Number: - MF(分子式): C23H25BrN5NaO5 MW(分子量): 554.37
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|
| 中文别名 | Cgp 33304 |
| 英文别名 | Cgp 33304; Cgp33304; Cgp-33304. |
| CAS号 | 111130-14-4 |
| Inchi | InChI=1S/C23H26BrN5O5.Na/c1-4-6-16-19(8-7-15(14(3)30)21(16)31)33-9-5-10-34-20-12-18(13(2)11-17(20)24)25-23(32)22-26-28-29-27-22;/h7-8,11-12H,4-6,9-10H2,1-3H3,(H3,25,26,27,28,29,30,31,32);/q;+1/p-1 |
| InchiKey | RODQJMRHNNVXAG-UHFFFAOYSA-M |
| 分子式 Formula | C23H25BrN5NaO5 |
| 分子量 Molecular Weight | 554.37 |
| 溶解度Solubility | |
| 性状 | Solid powder |
| 储藏条件 Storage conditions | Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years). |
| 产品说明 | Cgp 33304(CAS:111130-14-4):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。 |
| Introduction | Cgp 33304 is a dual leukotriene receptor antagonists and phospholipase A2 inhibiting agent. It may prevent hypoxia secondary to leukotriene induced bronchoconstriction in shock states. CGP 33304 has potential to be an useful therapeutic agent in acute ischemic disorders including traumatic shock. |
| Application1 | |
| Application2 | |
| Application3 |
| [1]Levitt MA, Lefer AM. Efficacy of two leukotriene antagonists in rat traumatic shock. Methods Find Exp Clin Pharmacol. 1987 May;9(5):269-73. PubMed PMID: 3613754. |
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


